论文部分内容阅读
目的:探讨微量肝素静滴联合氨溴索雾化吸入治疗支气管肺炎的效果。方法:选择100例支气管肺炎患者,随机分为对照组和观察组,每组50例。对照组采用常规治疗,观察组在对照组的基础上加用微量肝素静滴联合氨溴索雾化吸入治疗,5天为一个疗程,观察比较两组患者的治疗效果。结果:观察组患者中的总有效率92.50%,高于对照组的82.50%(P<0.05);治疗后观察组中患者的咳嗽消失时间、喘憋消失时间、肺部湿啰音消失时间均比对照组短,差异有统计学意义(P<0.05)。结论:支气管肺炎在综合治疗的基础上加用微量肝素静滴联合氨溴索雾化吸入治疗疗效显著,值得临床推广应用。
Objective: To investigate the effect of intravenous injection of trace heparin and ambroxol inhalation on bronchopneumonia. Methods: 100 cases of bronchial pneumonia were selected and randomly divided into control group and observation group, 50 cases in each group. The control group was treated with conventional therapy. The observation group was treated with intravenous injection of trace heparin and ambroxol inhalation on the basis of the control group. The course of treatment was 5 days. The therapeutic effect was observed and compared between the two groups. Results: The total effective rate in the observation group was 92.50%, which was higher than that in the control group (82.50%) (P <0.05). After treatment, the cough disappearance time, the disappearance of wheezing, the disappearance time of pulmonary wet rales Shorter than the control group, the difference was statistically significant (P <0.05). Conclusion: Bronchopneumonia combined with microelement heparin infusion and ambroxol inhalation is effective in treating bronchopneumonia on the basis of comprehensive treatment, which is worthy of clinical application.